Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Decibel Therapeutics Inc (DBTX)

Decibel Therapeutics Inc (DBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DBTX, CPRI, CEQP, ESTE PR Newswire - Tue Sep 12, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DBTX : 4.91 (-0.81%)
CPRI : 21.13 (-1.03%)
CEQP : 28.26 (+4.36%)
ESTE : 21.17 (+0.47%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, VRTV, CTG, DBTX PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TRHC : 10.50 (+0.86%)
VRTV : 169.99 (+0.02%)
CTG : 10.50 (+0.10%)
DBTX : 4.91 (-0.81%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRTV, CTG, DBTX, CPRI PR Newswire - Tue Aug 29, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VRTV : 169.99 (+0.02%)
CTG : 10.50 (+0.10%)
DBTX : 4.91 (-0.81%)
CPRI : 21.13 (-1.03%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, DBTX, TRHC PR Newswire - Tue Aug 22, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMNB : 47.76 (-0.33%)
DBTX : 4.91 (-0.81%)
TRHC : 10.50 (+0.86%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, DBTX, VRTV, ZYNE PR Newswire - Tue Aug 15, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TRHC : 10.50 (+0.86%)
DBTX : 4.91 (-0.81%)
VRTV : 169.99 (+0.02%)
ZYNE : 1.3000 (+2.36%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, DBTX, WMC, MITT PR Newswire - Wed Aug 9, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CTG : 10.50 (+0.10%)
DBTX : 4.91 (-0.81%)
WMC : 9.18 (+4.44%)
MITT : 7.15 (+0.42%)
Shareholder Alert: Ademi LLP investigates whether Decibel Therapeutics, Inc. has obtained a Fair Price in its transaction with Regeneron PR Newswire - Wed Aug 9, 2023

/PRNewswire/ -- Ademi LLP is investigating Decibel (NASDAQ: DBTX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

DBTX : 4.91 (-0.81%)
Housing, Manufacturing Stats Due Next Week Baystreet - Fri Mar 10, 2023

Housing, Manufacturing Stats Due Next Week Monday U.S. Featured Earnings GitLab Inc. ...

GTLB : 60.45 (+0.73%)
DLO : 11.61 (+0.09%)
GOL : 2.72 (+3.23%)
LEN : 138.00 (unch)
SMAR : 56.00 (+0.05%)
S : 22.69 (+1.16%)
ADBE : 447.94 (+0.27%)
FIVE : 107.50 (-0.18%)
FDX : 271.84 (+1.05%)
DG : 74.64 (+0.03%)
JBL : 147.77 (+1.44%)
JANX : 56.14 (-1.07%)
Decibel Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Update Globe Newswire - Wed Aug 10, 2022

- Announced positive data from interim analysis of Phase 1b clinical trial of DB-020 in patients receiving cisplatin chemotherapy; data support continued...

DBTX : 4.91 (-0.81%)
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy Globe Newswire - Tue Jun 28, 2022

- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support...

DBTX : 4.91 (-0.81%)

Barchart Exclusives

Truist Analysts Love This Dividend Stock With a 15% Yield Barchart - Tue Dec 24, 6:30PM CST
Truist analysts are bullish on Mach Natural Resources (MNR), a new energy stock offering a 15% dividend yield and 45.5% upside potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot